세계의 안과용 의약품 시장예측 2021년-2026년

■ 영문 제목 : Global Opthalmic Pharmaceutical Drugs Market Growth 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K02121 입니다.■ 상품코드 : LPI-2201K02121
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 100
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산₩5,124,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩7,686,000견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩10,248,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 안과용 의약품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (항녹내장, 항감염증, 항염증제, 항알레르기)와 용도별 시장규모 (병원 약국, 약국, 온라인 약국, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 안과용 의약품 시장 점유율
- 지역별 안과용 의약품 시장규모
- 주요지역의 종류별 시장규모 (항녹내장, 항감염증, 항염증제, 항알레르기)
- 주요지역의 용도별 시장규모 (병원 약국, 약국, 온라인 약국, 기타)
- 미주의 안과용 의약품 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 안과용 의약품 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 안과용 의약품 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 안과용 의약품 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 안과용 의약품 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Johnson & Johnson, Carl-Zeiss, Ellex Medical Lasers, Essilor International, Hoya Corporation, Insight Vision, Nidek, Novagali Pharma, Topcon Corporation, Ziemer Ophthalmic Systems
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Opthalmic Pharmaceutical Drugs will have significant change from previous year. By the most conservative estimates of global Opthalmic Pharmaceutical Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Opthalmic Pharmaceutical Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Opthalmic Pharmaceutical Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Anti-glaucoma
Anti-infection
Anti-inflammatory
Anti-allergy

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacies
Drug Stores
Online Pharmacies
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Johnson & Johnson
Carl-Zeiss
Ellex Medical Lasers
Essilor International
Hoya Corporation
Insight Vision
Nidek
Novagali Pharma
Topcon Corporation
Ziemer Ophthalmic Systems

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opthalmic Pharmaceutical Drugs Consumption 2016-2026
2.1.2 Opthalmic Pharmaceutical Drugs Consumption CAGR by Region
2.2 Opthalmic Pharmaceutical Drugs Segment by Type
2.2.1 Anti-glaucoma
2.2.2 Anti-infection
2.2.3 Anti-inflammatory
2.2.4 Anti-allergy
2.3 Opthalmic Pharmaceutical Drugs Sales by Type
2.3.1 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Opthalmic Pharmaceutical Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Opthalmic Pharmaceutical Drugs Sale Price by Type (2016-2021)
2.4 Opthalmic Pharmaceutical Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Opthalmic Pharmaceutical Drugs Sales by Application
2.5.1 Global Opthalmic Pharmaceutical Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Opthalmic Pharmaceutical Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Opthalmic Pharmaceutical Drugs Sale Price by Application (2016-2021)

3 Global Opthalmic Pharmaceutical Drugs by Company
3.1 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Company
3.1.1 Global Opthalmic Pharmaceutical Drugs Sales by Company (2019-2021)
3.1.2 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Company (2019-2021)
3.2 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Company
3.2.1 Global Opthalmic Pharmaceutical Drugs Revenue by Company (2019-2021)
3.2.2 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Opthalmic Pharmaceutical Drugs Sale Price by Company
3.4 Global Manufacturers Opthalmic Pharmaceutical Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opthalmic Pharmaceutical Drugs Product Location Distribution
3.4.2 Players Opthalmic Pharmaceutical Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Opthalmic Pharmaceutical Drugs by Region
4.1 Global Opthalmic Pharmaceutical Drugs by Region
4.1.1 Global Opthalmic Pharmaceutical Drugs Sales by Region
4.1.2 Global Opthalmic Pharmaceutical Drugs Revenue by Region
4.2 Americas Opthalmic Pharmaceutical Drugs Sales Growth
4.3 APAC Opthalmic Pharmaceutical Drugs Sales Growth
4.4 Europe Opthalmic Pharmaceutical Drugs Sales Growth
4.5 Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Growth

5 Americas
5.1 Americas Opthalmic Pharmaceutical Drugs Sales by Country
5.1.1 Americas Opthalmic Pharmaceutical Drugs Sales by Country (2016-2021)
5.1.2 Americas Opthalmic Pharmaceutical Drugs Revenue by Country (2016-2021)
5.2 Americas Opthalmic Pharmaceutical Drugs Sales by Type
5.3 Americas Opthalmic Pharmaceutical Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Opthalmic Pharmaceutical Drugs Sales by Region
6.1.1 APAC Opthalmic Pharmaceutical Drugs Sales by Region (2016-2021)
6.1.2 APAC Opthalmic Pharmaceutical Drugs Revenue by Region (2016-2021)
6.2 APAC Opthalmic Pharmaceutical Drugs Sales by Type
6.3 APAC Opthalmic Pharmaceutical Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Opthalmic Pharmaceutical Drugs by Country
7.1.1 Europe Opthalmic Pharmaceutical Drugs Sales by Country (2016-2021)
7.1.2 Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2016-2021)
7.2 Europe Opthalmic Pharmaceutical Drugs Sales by Type
7.3 Europe Opthalmic Pharmaceutical Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Opthalmic Pharmaceutical Drugs by Country
8.1.1 Middle East & Africa Opthalmic Pharmaceutical Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Opthalmic Pharmaceutical Drugs Sales by Type
8.3 Middle East & Africa Opthalmic Pharmaceutical Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opthalmic Pharmaceutical Drugs Distributors
10.3 Opthalmic Pharmaceutical Drugs Customer

11 Global Opthalmic Pharmaceutical Drugs Market Forecast
11.1 Global Opthalmic Pharmaceutical Drugs Forecast by Region
11.1.1 Global Opthalmic Pharmaceutical Drugs Forecast by Regions (2021-2026)
11.2.2 Global Opthalmic Pharmaceutical Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Opthalmic Pharmaceutical Drugs Forecast by Type
11.7 Global Opthalmic Pharmaceutical Drugs Forecast by Application

12 Key Players Analysis
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Information
12.1.2 Johnson & Johnson Opthalmic Pharmaceutical Drugs Product Offered
12.1.3 Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Johnson & Johnson Main Business Overview
12.1.5 Johnson & Johnson Latest Developments
12.2 Carl-Zeiss
12.2.1 Carl-Zeiss Company Information
12.2.2 Carl-Zeiss Opthalmic Pharmaceutical Drugs Product Offered
12.2.3 Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Carl-Zeiss Main Business Overview
12.2.5 Carl-Zeiss Latest Developments
12.3 Ellex Medical Lasers
12.3.1 Ellex Medical Lasers Company Information
12.3.2 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product Offered
12.3.3 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Ellex Medical Lasers Main Business Overview
12.3.5 Ellex Medical Lasers Latest Developments
12.4 Essilor International
12.4.1 Essilor International Company Information
12.4.2 Essilor International Opthalmic Pharmaceutical Drugs Product Offered
12.4.3 Essilor International Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Essilor International Main Business Overview
12.4.5 Essilor International Latest Developments
12.5 Hoya Corporation
12.5.1 Hoya Corporation Company Information
12.5.2 Hoya Corporation Opthalmic Pharmaceutical Drugs Product Offered
12.5.3 Hoya Corporation Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Hoya Corporation Main Business Overview
12.5.5 Hoya Corporation Latest Developments
12.6 Insight Vision
12.6.1 Insight Vision Company Information
12.6.2 Insight Vision Opthalmic Pharmaceutical Drugs Product Offered
12.6.3 Insight Vision Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Insight Vision Main Business Overview
12.6.5 Insight Vision Latest Developments
12.7 Nidek
12.7.1 Nidek Company Information
12.7.2 Nidek Opthalmic Pharmaceutical Drugs Product Offered
12.7.3 Nidek Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Nidek Main Business Overview
12.7.5 Nidek Latest Developments
12.8 Novagali Pharma
12.8.1 Novagali Pharma Company Information
12.8.2 Novagali Pharma Opthalmic Pharmaceutical Drugs Product Offered
12.8.3 Novagali Pharma Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Novagali Pharma Main Business Overview
12.8.5 Novagali Pharma Latest Developments
12.9 Topcon Corporation
12.9.1 Topcon Corporation Company Information
12.9.2 Topcon Corporation Opthalmic Pharmaceutical Drugs Product Offered
12.9.3 Topcon Corporation Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Topcon Corporation Main Business Overview
12.9.5 Topcon Corporation Latest Developments
12.10 Ziemer Ophthalmic Systems
12.10.1 Ziemer Ophthalmic Systems Company Information
12.10.2 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product Offered
12.10.3 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Ziemer Ophthalmic Systems Main Business Overview
12.10.5 Ziemer Ophthalmic Systems Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Opthalmic Pharmaceutical Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Anti-glaucoma
Table 3. Major Players of Anti-infection
Table 4. Major Players of Anti-inflammatory
Table 5. Major Players of Anti-allergy
Table 6. Global Opthalmic Pharmaceutical Drugs Sales by Type (2016-2021) & (Kg)
Table 7. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2016-2021)
Table 8. Global Opthalmic Pharmaceutical Drugs Revenue by Type (2016-2021) & ($ million)
Table 9. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2016-2021)
Table 10. Global Opthalmic Pharmaceutical Drugs Sale Price by Type (2016-2021)
Table 11. Global Opthalmic Pharmaceutical Drugs Sales by Application (2016-2021) & (Kg)
Table 12. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2016-2021)
Table 13. Global Opthalmic Pharmaceutical Drugs Value by Application (2016-2021)
Table 14. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2016-2021)
Table 15. Global Opthalmic Pharmaceutical Drugs Sale Price by Application (2016-2021)
Table 16. Global Opthalmic Pharmaceutical Drugs Sales by Company (2019-2021) & (Kg)
Table 17. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Company (2019-2021)
Table 18. Global Opthalmic Pharmaceutical Drugs Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Company (2019-2021)
Table 20. Global Opthalmic Pharmaceutical Drugs Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Opthalmic Pharmaceutical Drugs Producing Area Distribution and Sales Area
Table 22. Players Opthalmic Pharmaceutical Drugs Products Offered
Table 23. Opthalmic Pharmaceutical Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Opthalmic Pharmaceutical Drugs Sales by Region (2016-2021) (Kg)
Table 27. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2016-2021)
Table 28. Global Opthalmic Pharmaceutical Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2016-2021)
Table 30. Americas Opthalmic Pharmaceutical Drugs Sales by Country (2016-2021) & (Kg)
Table 31. Americas Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2016-2021)
Table 32. Americas Opthalmic Pharmaceutical Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2016-2021)
Table 34. Americas Opthalmic Pharmaceutical Drugs Sales by Type (2016-2021) & (Kg)
Table 35. Americas Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2016-2021)
Table 36. Americas Opthalmic Pharmaceutical Drugs Sales by Application (2016-2021) & (Kg)
Table 37. Americas Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2016-2021)
Table 38. APAC Opthalmic Pharmaceutical Drugs Sales by Region (2016-2021) & (Kg)
Table 39. APAC Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2016-2021)
Table 40. APAC Opthalmic Pharmaceutical Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2016-2021)
Table 42. APAC Opthalmic Pharmaceutical Drugs Sales by Type (2016-2021) & (Kg)
Table 43. APAC Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2016-2021)
Table 44. APAC Opthalmic Pharmaceutical Drugs Sales by Application (2016-2021) & (Kg)
Table 45. APAC Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2016-2021)
Table 46. Europe Opthalmic Pharmaceutical Drugs Sales by Country (2016-2021) & (Kg)
Table 47. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2016-2021)
Table 48. Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2016-2021)
Table 50. Europe Opthalmic Pharmaceutical Drugs Sales by Type (2016-2021) & (Kg)
Table 51. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2016-2021)
Table 52. Europe Opthalmic Pharmaceutical Drugs Sales by Application (2016-2021) & (Kg)
Table 53. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales by Country (2016-2021) & (Kg)
Table 55. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales by Type (2016-2021) & (Kg)
Table 59. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales by Application (2016-2021) & (Kg)
Table 61. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Opthalmic Pharmaceutical Drugs
Table 63. Key Application and Potential Industries of Opthalmic Pharmaceutical Drugs
Table 64. Key Challenges of Opthalmic Pharmaceutical Drugs
Table 65. Key Trends of Opthalmic Pharmaceutical Drugs
Table 66. Opthalmic Pharmaceutical Drugs Distributors List
Table 67. Opthalmic Pharmaceutical Drugs Customer List
Table 68. Global Opthalmic Pharmaceutical Drugs Sales Forecast by Region (2021-2026) & (Kg)
Table 69. Global Opthalmic Pharmaceutical Drugs Consumption Market Forecast by Region
Table 70. Global Opthalmic Pharmaceutical Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Opthalmic Pharmaceutical Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Opthalmic Pharmaceutical Drugs Sales Forecast by Country (2021-2026) & (Kg)
Table 73. Americas Opthalmic Pharmaceutical Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Opthalmic Pharmaceutical Drugs Sales Forecast by Region (2021-2026) & (Kg)
Table 75. APAC Opthalmic Pharmaceutical Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Opthalmic Pharmaceutical Drugs Sales Forecast by Country (2021-2026) & (Kg)
Table 77. Europe Opthalmic Pharmaceutical Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Forecast by Country (2021-2026) & (Kg)
Table 79. Middle East & Africa Opthalmic Pharmaceutical Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Opthalmic Pharmaceutical Drugs Sales Forecast by Type (2021-2026) & (Kg)
Table 81. Global Opthalmic Pharmaceutical Drugs Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Opthalmic Pharmaceutical Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Opthalmic Pharmaceutical Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Opthalmic Pharmaceutical Drugs Sales Forecast by Application (2021-2026) & (Kg)
Table 85. Global Opthalmic Pharmaceutical Drugs Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Opthalmic Pharmaceutical Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Opthalmic Pharmaceutical Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 88. Johnson & Johnson Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Opthalmic Pharmaceutical Drugs Product Offered
Table 90. Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. Carl-Zeiss Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Carl-Zeiss Opthalmic Pharmaceutical Drugs Product Offered
Table 95. Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 96. Carl-Zeiss Main Business
Table 97. Carl-Zeiss Latest Developments
Table 98. Ellex Medical Lasers Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product Offered
Table 100. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 101. Ellex Medical Lasers Main Business
Table 102. Ellex Medical Lasers Latest Developments
Table 103. Essilor International Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Essilor International Opthalmic Pharmaceutical Drugs Product Offered
Table 105. Essilor International Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 106. Essilor International Main Business
Table 107. Essilor International Latest Developments
Table 108. Hoya Corporation Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Hoya Corporation Opthalmic Pharmaceutical Drugs Product Offered
Table 110. Hoya Corporation Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 111. Hoya Corporation Main Business
Table 112. Hoya Corporation Latest Developments
Table 113. Insight Vision Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Insight Vision Opthalmic Pharmaceutical Drugs Product Offered
Table 115. Insight Vision Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 116. Insight Vision Main Business
Table 117. Insight Vision Latest Developments
Table 118. Nidek Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Nidek Opthalmic Pharmaceutical Drugs Product Offered
Table 120. Nidek Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 121. Nidek Main Business
Table 122. Nidek Latest Developments
Table 123. Novagali Pharma Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novagali Pharma Opthalmic Pharmaceutical Drugs Product Offered
Table 125. Novagali Pharma Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 126. Novagali Pharma Main Business
Table 127. Novagali Pharma Latest Developments
Table 128. Topcon Corporation Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Topcon Corporation Opthalmic Pharmaceutical Drugs Product Offered
Table 130. Topcon Corporation Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 131. Topcon Corporation Main Business
Table 132. Topcon Corporation Latest Developments
Table 133. Ziemer Ophthalmic Systems Basic Information, Opthalmic Pharmaceutical Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product Offered
Table 135. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 136. Ziemer Ophthalmic Systems Main Business
Table 137. Ziemer Ophthalmic Systems Latest Developments
List of Figures
Figure 1. Picture of Opthalmic Pharmaceutical Drugs
Figure 2. Opthalmic Pharmaceutical Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opthalmic Pharmaceutical Drugs Sales Growth Rate 2016-2026 (Kg)
Figure 7. Global Opthalmic Pharmaceutical Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Opthalmic Pharmaceutical Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Anti-glaucoma
Figure 10. Product Picture of Anti-infection
Figure 11. Product Picture of Anti-inflammatory
Figure 12. Product Picture of Anti-allergy
Figure 13. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type in 2020
Figure 14. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2016-2021)
Figure 15. Opthalmic Pharmaceutical Drugs Consumed in Hospital Pharmacies
Figure 16. Global Opthalmic Pharmaceutical Drugs Market: Hospital Pharmacies (2016-2021) & (Kg)
Figure 17. Opthalmic Pharmaceutical Drugs Consumed in Drug Stores
Figure 18. Global Opthalmic Pharmaceutical Drugs Market: Drug Stores (2016-2021) & (Kg)
Figure 19. Opthalmic Pharmaceutical Drugs Consumed in Online Pharmacies
Figure 20. Global Opthalmic Pharmaceutical Drugs Market: Online Pharmacies (2016-2021) & (Kg)
Figure 21. Opthalmic Pharmaceutical Drugs Consumed in Others
Figure 22. Global Opthalmic Pharmaceutical Drugs Market: Others (2016-2021) & (Kg)
Figure 23. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2016-2021)
Figure 24. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application in 2020
Figure 25. Opthalmic Pharmaceutical Drugs Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Company in 2020
Figure 27. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Regions (2016-2021)
Figure 28. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region in 2020
Figure 29. Americas Opthalmic Pharmaceutical Drugs Sales 2016-2021 (Kg)
Figure 30. Americas Opthalmic Pharmaceutical Drugs Revenue 2016-2021 ($ Millions)
Figure 31. APAC Opthalmic Pharmaceutical Drugs Sales 2016-2021 (Kg)
Figure 32. APAC Opthalmic Pharmaceutical Drugs Revenue 2016-2021 ($ Millions)
Figure 33. Europe Opthalmic Pharmaceutical Drugs Sales 2016-2021 (Kg)
Figure 34. Europe Opthalmic Pharmaceutical Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales 2016-2021 (Kg)
Figure 36. Middle East & Africa Opthalmic Pharmaceutical Drugs Revenue 2016-2021 ($ Millions)
Figure 37. Americas Opthalmic Pharmaceutical Drugs Sales Market Share by Country in 2020
Figure 38. Americas Opthalmic Pharmaceutical Drugs Revenue Market Share by Country in 2020
Figure 39. Americas Opthalmic Pharmaceutical Drugs Sales Market Share by Type in 2020
Figure 40. Americas Opthalmic Pharmaceutical Drugs Sales Market Share by Application in 2020
Figure 41. United States Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Opthalmic Pharmaceutical Drugs Sales Market Share by Region in 2020
Figure 46. APAC Opthalmic Pharmaceutical Drugs Revenue Market Share by Regions in 2020
Figure 47. APAC Opthalmic Pharmaceutical Drugs Sales Market Share by Type in 2020
Figure 48. APAC Opthalmic Pharmaceutical Drugs Sales Market Share by Application in 2020
Figure 49. China Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Country in 2020
Figure 56. Europe Opthalmic Pharmaceutical Drugs Revenue Market Share by Country in 2020
Figure 57. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Type in 2020
Figure 58. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Application in 2020
Figure 59. Germany Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Opthalmic Pharmaceutical Drugs Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Application in 2020
Figure 68. Egypt Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Opthalmic Pharmaceutical Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
※본 조사보고서 [세계의 안과용 의약품 시장예측 2021년-2026년] (코드 : LPI-2201K02121) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 안과용 의약품 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!